EDITORIAL

Vol. 24 No. 1 (2023): ALPHA PSYCHIATRY
DOI: https://doi.org/10.5152/alphapsychiatry.2023.27122022

Article Sidebar

Full Text PDF
Published: Jan 9, 2023
Keywords:
AVES Editorial Office

Main Article Content

Sergio Machado
Laboratory of Physical Activity Neuroscience, Neurodiversity Institute, Queimados-RJ, Brazil
João Lucas Lima
Laboratory of Physical Activity Neuroscience, Neurodiversity Institute, Queimados-RJ, Brazil
Claudio Imperatori
Cognitive and Clinical Psychology Laboratory, Department of Human Sciences, European University of Rome, Rome, Italy
Alberto Souza de Sá Filho
Post Graduate Program of University Center of Anápolis (UniEVANGÉLICA), Anápolis, Brazil

Commentary: Is Torasemide a Potential Agent in the Treatment of Autism?

Main Article Content

Sergio Machado
Laboratory of Physical Activity Neuroscience, Neurodiversity Institute, Queimados-RJ, Brazil
João Lucas Lima
Laboratory of Physical Activity Neuroscience, Neurodiversity Institute, Queimados-RJ, Brazil
Claudio Imperatori
Cognitive and Clinical Psychology Laboratory, Department of Human Sciences, European University of Rome, Rome, Italy
Alberto Souza de Sá Filho
Post Graduate Program of University Center of Anápolis (UniEVANGÉLICA), Anápolis, Brazil

Abstract

Cite this article as: Machado S, Lima JL, Imperatori C, Souza de Sá Filho A. Commentary: Is torasemide a potential agent in the treatment of autism? Alpha Psychiatry. 2023;24(1):32-33.


Article Details